Company Overview

Yasho Industries Limited (Scrip Code: 541167, Symbol: YASHO) submitted its Investor Presentation for Q2FY27 to BSE and NSE pursuant to Regulation 30 of SEBI Listing Regulations. The presentation was dated October 28, 2026, and signed by Rupali Verma, Company Secretary & Compliance Officer.

Company Background

Yasho Industries Limited is a specialty chemicals company incorporated in 1985 by the Jhaveri family, with manufacturing since 1993. The company produces high-performance ingredients for industrial and consumer applications, including lubricant additives and rubber chemicals. The company has transformed from consumer-focused roots (1985-2010) to industrial chemicals (2010-2018), capacity build-out (2018-2023), and is now in a growth phase focusing on expansion and customer acquisition.

Q2 & H1 FY27 Financial Performance

Consolidated Income Statement (Q2FY27)

  • Revenue from Operations: ₹347.68 crore
  • Other Income: ₹0.25 crore
  • Total Income: ₹347.93 crore (90% YoY growth)
  • Cost of Material Consumed: ₹238.74 crore
  • Change in Inventories: -₹32.76 crore
  • Gross Profit: ₹141.95 crore (40.8% margin)
  • Employee Expenses: ₹20.42 crore
  • Other Expenses: ₹48.60 crore
  • EBITDA: ₹72.92 crore (21.0% margin, 118% YoY growth)
  • Depreciation: ₹14.58 crore
  • EBIT: ₹58.34 crore (16.8% margin)
  • Finance Cost: ₹13.07 crore
  • Profit Before Tax: ₹45.27 crore (13.0% margin)
  • Tax: ₹11.59 crore
  • Profit After Tax: ₹33.68 crore (9.7% margin)
  • EPS: ₹27.93

Consolidated Income Statement (H1FY27)

  • Revenue from Operations: ₹655.42 crore
  • Other Income: ₹1.56 crore
  • Total Income: ₹656.98 crore (72% YoY growth)
  • Gross Profit: ₹272.93 crore (41.6% margin)
  • EBITDA: ₹147.33 crore (22.5% margin)
  • EBIT: ₹118.60 crore (18.1% margin)
  • Profit Before Tax: ₹94.24 crore (14.4% margin)
  • Profit After Tax: ₹69.73 crore (10.6% margin)
  • EPS: ₹57.84

Consolidated Balance Sheet (H1FY27)

  • Property, plant and equipment: ₹595.38 crore
  • Capital Work-in-Progress: ₹131.05 crore
  • Right of Use Asset: ₹9.20 crore
  • Other Intangible Assets: ₹18.20 crore
  • Total Non-Current Assets: ₹782.38 crore
  • Inventories: ₹365.86 crore
  • Trade Receivable: ₹248.97 crore
  • Cash and Cash Equivalents: ₹3.57 crore
  • Total Current Assets: ₹735.21 crore
  • Total Assets: ₹1,517.59 crore
  • Total Equity: ₹511.73 crore (Share Capital: ₹12.06 crore)
  • Borrowings: ₹286.34 crore (non-current) + ₹329.16 crore (current)
  • Total Liabilities: ₹1,005.86 crore

Consolidated Cash Flow (H1FY27)

  • Cash from Operating Activities: ₹96.96 crore
  • Cash from Investing Activities: -₹138.52 crore
  • Cash from Financing Activities: ₹43.06 crore
  • Net change in Cash: ₹0.55 crore
  • Ending Cash Balance: ₹3.57 crore

Operational Performance

  • Volume growth: 62% YoY in Q2FY27
  • Capacity utilization: 66% in Q2FY27
  • Revenue mix: Industrial Chemicals 90%, Consumer Chemicals 10%
  • Geographic mix: International 71%, Domestic 29%
  • Debt-to-EBITDA ratio: 2.09x in H1FY27 (improved from 3.74x in FY26)

Growth Strategy and Capex Update

  • Total FY27 capex outlay: ₹250 crore
  • Committed capex for machinery: ₹64.10 crore
  • Committed capex for buildings: ₹80 crore
  • Financial closure completed for planned FY27 capex with long-term debt of ₹150 crore tied up
  • For MNC contract: Received ₹120.03 crore to date, committed capex ₹97.60 crore
  • Equipment delivery and installation expected in Q3FY27
  • Trial production commencement expected in Q4FY27
  • Commercialization expected in Q1FY28
  • FY28 revenue guidance maintained at over ₹1,600 crore

Manufacturing Facilities

  • Pakhajan Plant: 42-acre site with 50% land in use, peak revenue capacity ₹900-950 crore
  • Vapi Plant: Multi-purpose unit, peak revenue capacity ₹650-700 crore
  • R&D Center: 25,000+ sq ft at Pakhajan with 50+ researchers

Shareholder Information

  • Investor Relations contacts provided: Sejal Bhattar and Nikunj Seth